Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway (Q28580167)

From Wikidata

Jump to navigation Jump to search

scientific journal article

Language	Label	Description	Also known as
English	Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway	scientific journal article

Statements

scholarly article

1 reference

31 January 2017

Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway (English)

1 reference

31 January 2017

author name string

Yingxia Bao

1

1 reference

31 January 2017

Ruifang Li

2

1 reference

31 January 2017

Jianmin Jiang

3

1 reference

31 January 2017

Birong Cai

4

1 reference

31 January 2017

Jie Gao

5

1 reference

31 January 2017

Kang Le

6

1 reference

31 January 2017

Fangyan Zhang

7

1 reference

31 January 2017

Shaorui Chen

8

1 reference

31 January 2017

Peiqing Liu

9

1 reference

31 January 2017

publication date

1 October 2008

1 reference

31 January 2017

Molecular and Cellular Biochemistry

1 reference

31 January 2017

317

1 reference

31 January 2017

1-2

1 reference

31 January 2017

189–196

1 reference

31 January 2017

https://scigraph.springernature.com/pub.10.1007/s11010-008-9848-8

0 references

Peroxisome proliferator-activated receptor-gamma activators inhibit endothelin-1-related cardiac hypertrophy in rats

1 reference

https://api.crossref.org/works/10.1007%2FS11010-008-9848-8

21 January 2018

Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interference of antihypertrophic molecules and signaling pathways with the Ca2+-calcineurin-NFAT cascade in cardiac myocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcriptional regulation by calcium, calcineurin, and NFAT

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcineurin and human heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuropeptide Y induces cardiomyocyte hypertrophy via calcineurin signaling in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of Interleukin-4 Production in CD4+T Cells by Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Ligands: Involvement of Physical Association between PPAR-γ and the Nuclear Factor of Activated T Cells Transcription Factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An overview on biological mechanisms of PPARs.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcineurin in human heart hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of peroxisome proliferator-activated receptor-alpha prevents glycogen synthase 3beta phosphorylation and inhibits cardiac hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Roles of calcineurin and calcium/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does the inhibition of c-myc expression mediate the anti-tumor activity of PPAR's ligands in prostate cancer cell lines?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Negative regulators of cardiac hypertrophy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptors in the cardiovascular system

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Delta12, 14-prostaglandin J2

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcium-calcineurin signaling in the regulation of cardiac hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphorylation of NFATc4 by p38 mitogen-activated protein kinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Upregulation of TRPC1 in the development of cardiac hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A role for the p38 MAP kinase pathway in the nuclear shuttling of NFATp

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

14-3-3 proteins regulate glycogen synthase 3beta phosphorylation and inhibit cardiomyocyte hypertrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imbalance between CaM kinase II and calcineurin activities impairs caffeine-induced calcium release in hypertrophic cardiomyocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcineurin--the missing link in cardiac hypertrophy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18600431

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11010-008-9848-8

1 reference

31 January 2017

Dimensions Publication ID

0 references

1 reference

31 January 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28580167&oldid=2030844177"